Cargando…
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
Depletion of immunosuppressive tumor-associated macrophages (TAMs) or reprogramming toward a proinflammatory activation state represent different strategies to therapeutically target this abundant myeloid population. In this study, we report that inhibition of colony-stimulating factor-1 receptor (C...
Autores principales: | Hoves, Sabine, Ooi, Chia-Huey, Wolter, Carsten, Sade, Hadassah, Bissinger, Stefan, Schmittnaegel, Martina, Ast, Oliver, Giusti, Anna M., Wartha, Katharina, Runza, Valeria, Xu, Wei, Kienast, Yvonne, Cannarile, Michael A., Levitsky, Hyam, Romagnoli, Solange, De Palma, Michele, Rüttinger, Dominik, Ries, Carola H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839760/ https://www.ncbi.nlm.nih.gov/pubmed/29436396 http://dx.doi.org/10.1084/jem.20171440 |
Ejemplares similares
-
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy
por: Kashyap, Abhishek S., et al.
Publicado: (2020) -
The Tumor Milieu Promotes Functional Human Tumor-Resident Plasmacytoid Dendritic Cells in Humanized Mouse Models
por: Maser, Ilona-Petra, et al.
Publicado: (2020) -
PK/PD Mediated Dose Optimization of Emactuzumab, a CSF1R Inhibitor, in Patients With Advanced Solid Tumors and Diffuse‐Type Tenosynovial Giant Cell Tumor
por: Smart, Kevin, et al.
Publicado: (2020) -
Towards Curative Cancer Immunotherapy: Overcoming Posttherapy Tumor Escape
por: Zhou, Gang, et al.
Publicado: (2012) -
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
por: Cannarile, Michael A., et al.
Publicado: (2017)